Clinical Trial Update: Efficacy and Safety of Soliqua Versus Lantus in Ethnically/Racially Diverse Patients With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic Agents [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Soliqua to Lantus in ethnically diverse patients with type 2 diabetes uncontrolled on basal insulin and oral agents; study terminated wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Lantus (insulin glargine)
• Soliqua

Snippet

Sponsor: Sanofi | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: TERMINATED | Results posted: 2020-01-13